Previous reports on the prognostic value of diabetes mellitus for cardiac complications after vascular surgery show divergent results, especially in regards to the role of type 2 diabetes as a cardiac risk factor, which remains unclear. The aim of this study was to assess the impact of type 2 diabetes on 30-day cardiac complications after vascular surgery.
Cardiac complications are a major cause of morbidity and mortality after vascular surgery 1 . Diabetes mellitus (DM) is highly prevalent in this population 2 . Both type 1 DM (DM1, characterised by immune-mediated beta-cell destruction leading to absolute insulin deficiency) and type 2 DM (DM2, characterised by insulin resistance) lead to atherosclerotic complications, such as myocardial infarction, stroke and renal failure 3, 4 . DM1 is generally considered a risk factor for postoperative cardiac events 1 . However, the effect of DM2 on the incidence of cardiac complications after vascular surgery remains unclear 1, 5, 6 .
We have previously examined the effect of a variety of factors on perioperative cardiovascular outcomes in vascular surgery using a prospectively collected database, addition to which is ongoing. These studies have considered the effects of haemoglobin concentration 7 , blood type 8 , aortic valve calcium 9 and serum phosphorus level 10 . The aim of this further analysis of our database is to specifically assess the impact of DM2 on cardiac complications after vascular surgery.
METHODS

Study population
The study population of this retrospective cohort study consisted of 1484 patients who underwent elective vascular surgery between 2002 and 2011.
Patients undergoing open or endovascular aortoiliac reconstruction, infra-inguinal arterial revascularisation and carotid endarterectomy were included in the study. The study was performed at a single site: the Department of Vascular Surgery of the Erasmus university Medical Center, Rotterdam, The Netherlands. The study complies with the declaration of Helsinki and was approved by the institutional Review Board of the Erasmus Medical Center (Approval No. MEC-2011-510). All data were obtained from computerised medical records.
Baseline characteristics
A detailed medical history was obtained from all patients prior to surgery, with the emphasis on cardiovascular history and risk factors including age, gender, history of congestive heart failure, ischaemic heart disease, coronary revascularisation, chronic kidney disease (serum creatinine >177 µmol/l), hypertension, cerebrovascular disease, body mass index, anaemia (as previously defined) 7 , highrisk surgery (open aorto-iliac repair) and chronic obstructive pulmonary disease. Also, the use of beta-blockers, statins, aspirin, oral anticoagulants, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, diuretics or nitrates prior to surgery was recorded. A Revised Cardiac Risk index 1 score was calculated for all patients.
Diabetes mellitus
Patients were categorised as no DM, DM1 or DM2 based on medication use and previous diagnosis. The use of insulin and oral anti-diabetic medication was recorded in all patients. Patients with DM1 were excluded from the analysis. The last available preoperative glycosylated haemoglobin (A1C) value was obtained for DM2 patients.
Study outcomes
Serial electrocardiograms and troponin T measurements were routinely obtained prior to surgery and postoperatively three times a week while admitted to the hospital. Troponin T was measured using the TropT version 2 assay (Roche Diagnostics, Mannheim, germany). The study endpoint was 30-day cardiovascular complications, a composite of cardiovascular mortality, non-fatal myocardial infarction, new or worsened congestive heart failure, new ventricular arrhythmias (requiring immediate cardioversion, cardiopulmonary resuscitation or pacing) and asymptomatic troponin T release. Cardiovascular death was defined as any death from cerebro-or cardiovascular cause, including death following stroke, myocardial infarction, congestive heart failure and arrhythmia, or sudden unexpected death. Myocardial infarction was defined as postoperative characteristic rise and fall of troponin T levels above the 99th percentile, with either electrocardiographic or clinical signs of myocardial ischaemia. Asymptomatic troponin T release was defined as at least one troponin T value above the 99th percentile in the absence of electrocardiographic and clinical signs of myocardial ischaemia and in the absence of other cardiac complications. Patients were routinely scheduled for a follow-up visit 30 days after surgery. in patients still admitted or readmitted, follow-up was completed using medical records.
Statistical analysis
Dichotomous data are presented as numbers and percentages. Continuous data are presented as mean ± standard deviation. Dichotomous data were compared using the chi-square test, continuous data were compared using analysis of variance. univariate and multivariate logistic regression models were used to assess the prognostic value of DM2 for 30-day cardiovascular complications. Congestive heart failure, ischaemic heart disease, chronic kidney disease, cerebrovascular disease, chronic obstructive pulmonary disease, age, gender, body mass index, current smoking, high-risk surgical procedure and medication use were considered as possible confounders. A threshold of P <0.20 on univariate analysis was used for selection for entry into multivariate analysis. Preoperative haemoglobin levels were unavailable in 10.1% of all patients. We therefore examined a multivariate model including anaemia as an additional analysis. A two-sided P value of <0.05 was considered significant for all tests. All analyses were performed using Predictive Analysis Software version 17.0 (SPSS inc., Chicago, illinois, uSA).
RESulTS
The baseline population consisted of 1484 patients. Of these, 22 had DM1 and were excluded from analysis. The remaining study population of 1462 patients underwent 296 carotid endarterectomy, 707 aorto-iliac procedures and 459 infra-inguinal revascularisations. Endovascular procedures were performed in 622 patients. The mean age was 68 years and the majority of patients were male (75%).
Baseline characteristics
Of the 1462 patients, 329 (22.5%) patients had DM2. Of those, 87 (26%) received insulin treatment and 242 (74%) were managed without insulin.
Patients with DM2 more frequently underwent infrainguinal revascularisation compared with patients without DM, as presented in Table 1 . Patients with DM2 had a higher incidence of ischaemic heart disease, chronic kidney disease, anaemia, hypertension and higher mean body mass index, compared with patients without diabetes. in addition, patients with DM2 more frequently received diuretics, oral anticoagulants and angiotensin converting enzyme inhibitors or receptor blockers.
30-day outcome
During 30-day follow-up, 223 (15.3%) patients suffered cardiovascular complications, including Other factors significantly associated with cardiac complications were high-risk type of surgery, history of congestive heart failure, renal failure and age, as demonstrated in Table 3 . Additional adjustment for anaemia did not change the association between 
Glucose control
Preoperative glycosylated haemoglobin measurements were available in 280 DM2 patients (80% of those on insulin and 86% of those not on insulin). Mean A1C was higher in the insulin treated group (7.68±1.75 vs 6.76±1.00%, P <0.01). Mean A1C was similar in the DM2 patients who did suffer a cardiac complication and those who did not (6.93±1.38 vs 7.00±1.28%, P=0.73).
DiSCuSSiON
The results of this study indicate that diabetes mellitus type 2 is an independent predictor of cardiac complications after vascular surgery. The cardiac event rate was similar in DM2 patients treated with and without insulin.
Diabetes is common in the general population with an estimated prevalence of 6.4% of adults worldwide, increasing with age 11 . These patients are at high risk of diabetic complications, both microvascular (nephropathy, retinopathy, neuropathy) and macrovascular (including peripheral arterial disease, myocardial infarction and stroke) 12 . Type 2 diabetes is the cause of the majority of diabetesrelated complications, as this type accounts for approximately 90 to 95% of all cases 11 .
Hyperglycaemia in itself promotes atherosclerosis through an incompletely understood mechanism in both DM1 and DM2. Hypotheses include increased formation of glycosylation end products, accumulation of cellular sorbitol and increased activity of vascular protein kinase C [13] [14] [15] . Also, in DM2, insulin resistance promotes atherogenic dyslipidaemia, hypertension, systemic inflammation, hypercoagulability and endothelial dysfunction, leading to atherosclerosis 3, 16 .
Atherosclerotic complications therefore occur in both type 1 and type 2 diabetes mellitus 3 . it is thus biologically plausible that both DM1 and DM2 are risk factors for cardiac complications after noncardiac surgery. However, previous reports show divergent results.
in their article on the Revised Cardiac Risk index, lee and colleagues assessed the role of insulin-treated diabetes and identified it as a major risk factor for cardiac complications after noncardiac surgery 1 . insulin use was associated with an increased risk of a composite endpoint including myocardial infarction, pulmonary oedema, ventricular fibrillation or primary cardiac arrest, and complete heart block, with an OR of 3.0 (95% Ci 1.3 to 7.1).
Diabetes mellitus was associated with a 2.6-fold increased risk of cardiac events and mortality after vascular surgery in a study by Eagle et al 17 . in a mixed surgical population studied by Boersma et al, DM was strongly associated with perioperative cardiovascular mortality (OR 3.8; 95% Ci 2.7 to 5.4) 6 . A study by Bolsin et al showed a significant association between DM and cardiac complications in a mixed intermediate and high-risk surgical population (OR 1.95; 95% Ci 1.35 to 2.00) 18 . These studies, among others, have led to the recognition of all DM as a risk factor for cardiac complications after non-cardiac surgery in the 2002 American College of Cardiology/American Heart Association guidelines on perioperative care 19 . However, as neither of these studies discriminated between diabetes types and/or insulin use, it is not clear to what extent type 1 and type 2 diabetes contributed to the role of diabetes as a risk factor.
The Vascular Study group of New England presented their cardiac risk index for vascular surgery in 2010 2 . in this analysis, DM is grouped into DM treated with and without insulin, and a composite endpoint including myocardial infarction, congestive heart failure and ventricular and atrial arrhythmias was used. DM treated with insulin was independently associated with the endpoint (OR 1.4; 95% Ci 1.1 to 1.9). in this study, the group of patients with insulin-treated diabetes may have consisted of both DM1 and insulin-treated DM2 patients. No significant association was observed for DM treated without insulin, with an OR of 1.0. However, given the large CI (0.8 to 1.3), no definite conclusions can be drawn regarding the effect of non insulin-dependent diabetes on cardiac complications after vascular surgery.
in an analysis of 6565 vascular surgical procedures by Hamdan et al, postoperative myocardial infarction occurred in 1.77% of patients with DM and in 1.30% of those without DM (and 1.13 vs 1.14% postoperative congestive heart failure) 5 . it is stated that diabetes does not influence the risk of cardiac complications after vascular surgery. unfortunately, no statistical analysis of these percentages is provided. Of note, the high prevalence of DM in the population of this study (62.3%) might limit generalisability to other vascular surgery populations.
Bolliger et al studied 360 DM2 patients undergoing major non-cardiac surgical procedures, including vascular, orthopaedic, abdominal and lung surgery and found that patients treated with insulin were at higher risk of 30-day major cardiac complications than those managed without insulin (7.4 vs 1.8%) 20 . This might be explained by the higher number of cardiac risk factors in patients treated with insulin. As 30-day cardiac complications were not the primary endpoint of this study, no further exploration with multivariate regression analysis was performed.
in the current study of 1484 vascular surgery patients, type 2 DM is significantly associated with perioperative cardiovascular events, a composite outcome including cardiac death, non-fatal myocardial infarction, congestive heart failure, ventricular arrhythmia, stroke and asymptomatic troponin release. Multivariate analysis demonstrated an adjusted OR of 1.80 (95% Ci 1.24 to 2.61), with similar ORs in DM2 patients managed with and without insulin. Haemoglobin A1C levels were similar in DM2 patients with and without a postoperative cardiac event, suggesting that preoperative glycaemic control is not a major determinant of cardiac complications after vascular surgery in type 2 diabetics.
Several limitations apply to this study. First, the study was performed retrospectively. Fasting glucose levels and glucose loading tests were not routinely obtained. Therefore, asymptomatic patients who fulfil the criteria of diabetes might have been misclassified as non-diabetic. This would result in an underestimation of the true effect of diabetes. We depended on previous diagnosis and classification of diabetes. Some misclassification of diabetes type might be present. Haemoglobin A1C levels were unavailable in 15% of DM2 patients. Furthermore, the study was performed in a high-risk vascular surgery population at a tertiary referral centre, which may limit generalisability to populations at lower risk of cardiac complications. We used a composite outcome measure including cardiac death, myocardial infarction, congestive heart failure, ventricular arrhythmia and asymptomatic troponin release. We feel that including asymptomatic troponin release in the outcome measure is justifiable given its detrimental effect on long-term prognosis 21 . Removal of asymptomatic troponin release from the composite endpoint did not affect the ORs obtained in multivariate analysis. We previously assessed the prognostic implications of preoperative anaemia, aortic valve sclerosis, serum phosphorus levels, and blood type in populations that consist (partially) of patients described in the current study. Preoperative anaemia 7 and elevated phosphorus levels 10 were identified as independent predictors of cardiac complications. We adjusted for anaemia in this multivariate analysis but phosphorus levels were only available in a minor part of the study population. Therefore, phosphorus levels were not considered for inclusion in the current analysis. Data on blood type 8 and aortic valve sclerosis 9 are not presented in the current study, as these factors were not associated with cardiac outcome in vascular surgery in our previous studies.
in conclusion, our data support the theory that type 2 DM is a major independent risk factor for cardiac complications in vascular surgery patients, regardless of the need for exogenous insulin. All DM, regardless of the type of diabetes and need for insulin therapy, should be considered a risk factor for cardiac complications after vascular surgery.
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